Can Ketamine Therapy Be Combined With Other Treatments or Medications?

Ketamine therapy has become a widely discussed option for people seeking relief from depression, anxiety, PTSD, and other mood-related conditions. However, most patients considering ketamine are not starting from scratch; they may already be taking prescription medications or using other forms of treatment. This often raises important questions about safety, compatibility, and whether certain combinations can improve or reduce results. Since ketamine works differently from traditional antidepressants, treatment planning should be carefully personalized and medically supervised.
In this blog, we’ll explore how ketamine therapy can be combined with other treatments and medications, and what to know before beginning care.

Key Takeaways

• Ketamine is rarely used alone. Most people receiving ketamine therapy are already taking psychiatric medications, and stopping them is usually not recommended. Ketamine can be safely combined with many common meds (including SSRIs and SNRIs), though some, like high-dose benzodiazepines and lamotrigine, may reduce its antidepressant effects.
• Some medication combinations need closer monitoring. SSRIs and SNRIs are generally safe to continue. MAOIs, ADHD stimulants, and cardiovascular medications may require careful monitoring of blood pressure and heart rate. Benzodiazepines and lamotrigine may blunt ketamine’s benefits.
• Treatment is individualized. Your prescriber may adjust dosing schedules, temporarily hold certain medications, or make other changes before starting ketamine. Never change your medication plan without medical guidance.
• Bring a complete list of medications and supplements. Research on interactions continues to evolve through clinical trials and real-world practice, and your care team needs full details to keep treatment safe. If you’re unsure about your current meds, schedule a consultation for personalized guidance.

How Ketamine Therapy Fits Into an Overall Treatment Plan

Ketamine therapy is used to treat several mental health conditions that haven’t responded well to standard approaches, and recognizing common myths about ketamine helps patients better understand why it is often added to, not substituted for, an existing treatment plan. IV ketamine and intranasal esketamine (Spravato) are most commonly prescribed for treatment-resistant depression, but they’re also used for suicidality, PTSD, some anxiety disorders like obsessive compulsive disorder and panic disorder, and certain chronic pain syndromes. The key thing to understand is that ketamine is almost always added to, not substituted for, an existing treatment plan.

Here’s why ketamine works differently from typical antidepressants and why that matters for combination treatment:

• Different mechanism of action: Traditional antidepressants like SSRIs work on serotonin, while ketamine works primarily as an NMDA receptor antagonist. This affects the glutamate system and triggers a cascade that enhances synaptic plasticity, essentially helping your brain form new, healthier connections.
• Rapid onset: While conventional depression medications can take 4–6 weeks to work, the effects of ketamine often appear within hours to days.
• Complementary pathways: Because ketamine works through the N-methyl-D-aspartate receptor system rather than serotonin or norepinephrine, it can often be safely combined with other drugs that target different brain pathways.

In the United States, intranasal esketamine is FDA-approved specifically to be used alongside an oral antidepressant, not as a standalone treatment. This illustrates that combination use isn’t just possible; for at least one ketamine-based treatment, it’s the standard of care.

When we talk about “combining treatments,” we mean both medication combinations (like SSRIs plus ketamine) and pairing ketamine with non-medication approaches, including exploring various therapies offered in ketamine clinics. These include:

• Psychotherapies like CBT and trauma-focused therapy
• Lifestyle changes such as exercise, sleep optimization, and nutrition
• Other brain-based treatments like TMS (transcranial magnetic stimulation)

An integrated plan, medications, therapy, plus careful monitoring generally lead to safer and more durable results than ketamine alone. Think of ketamine as opening a window; what you do during that window determines how much lasting benefit you get.

Combining Ketamine With Antidepressants

Most people receiving ketamine for depression or anxiety are already on an antidepressant. Stopping those prescribed medications is usually not recommended unless your psychiatrist identifies a specific clinical reason. The general rule: continue what’s working while adding ketamine for additional benefit.

Interactions differ by antidepressant class, and understanding these differences helps you make informed decisions with your treatment team. This section covers SSRIs, SNRIs, bupropion, and MAOIs separately. Many clinical trials and real-world clinics have reported safe concurrent use of ketamine with standard antidepressants, though blood pressure and side effect monitoring remain routine.

Before and after each ketamine infusion or intranasal dose, your team will typically check:

• Blood pressure and heart rate
• Mental status and mood
• Any emerging side effects

Let’s look at each antidepressant class in detail.

Ketamine and SSRIs

Combining ketamine with selective serotonin reuptake inhibitors, such as sertraline, fluoxetine, escitalopram, citalopram, paroxetine, and fluvoxamine, is generally considered safe. In fact, this is the most common medication combination seen in modern ketamine clinics.

The reason this combination works well comes down to mechanism: SSRIs act on serotonin reuptake, while ketamine acts primarily on glutamate and NMDA receptors. These are complementary rather than overlapping pathways.

Large real-world datasets and clinical experience have not shown a consistent reduction of ketamine’s antidepressant effect when SSRIs are continued. There’s no strong evidence that SSRIs need to be stopped before ketamine.

Possible side effects to watch for:

• Nausea
• Transient blood pressure rises
• Anxiety or agitation in sensitive patients

Serotonin syndrome appears to be very rare with this combination, though your team will monitor for it.

Practical tips for patients:

• Don’t change your SSRI dose on your own
• Bring an up-to-date medication list to your ketamine consultation
• Expect your team to adjust only if specific side effects or lack of response occur

Ketamine and SNRIs

Serotonin norepinephrine reuptake inhibitors, such as venlafaxine, desvenlafaxine, duloxetine, and levomilnacipran, are also commonly combined with ketamine for treatment-resistant depression and comorbid anxiety or pain conditions.

The main concern with this combination isn’t brain toxicity but cardiovascular effects. SNRIs can raise blood pressure and heart rate modestly, and ketamine can also cause short-lived increases. Together, these effects may add up.

What to expect at your appointments:

• Clinics typically check blood pressure before and after infusions or intranasal doses
• Sessions might be delayed or adjusted if resting blood pressure is significantly elevated (commonly above 140/90–150/95 mmHg, depending on clinic policy)

Published studies and clinical experience up to 2024 support continuing SNRIs in most cases. Dose adjustments may be considered for patients with uncontrolled hypertension, heart disease, or prior stroke.

Ketamine and Bupropion or Other Atypical Antidepressants

Bupropion (Wellbutrin) is commonly used for low energy, seasonal affective disorder, and smoking cessation. Other atypical antidepressants, like mirtazapine, vortioxetine, and vilazodone, may also be part of your regimen.

Bupropion and some atypicals can be mildly stimulating and may raise blood pressure and heart rate slightly. Since ketamine can also cause transient increases in vital signs, combined monitoring is important.

Based on available clinical reports, bupropion and other atypicals are generally considered safe to continue during ketamine therapy. Watch for:

• Insomnia
• Jitteriness
• Anxiety that might be amplified on treatment days

A note on seizures: Bupropion lowers seizure threshold at higher doses. However, standard ketamine protocols using subanesthetic doses have not been shown to significantly increase seizure risk in otherwise low-risk patients. Still, seizure history should always be discussed with your prescriber.

Ketamine and MAOIs

Monoamine oxidase inhibitors, like tranylcypromine, phenelzine, and isocarboxazid, are older antidepressants used for severe treatment-resistant depression, panic disorder, and social anxiety. Combining them with other drugs often raises concerns about blood pressure spikes and serotonin toxicity.

Here’s what the evidence shows: limited human data suggest no consistent hypertensive crisis or serotonin syndrome when ketamine is carefully combined with MAOIs. However, numbers are small, and caution is essential.

Key requirements for MAOI patients:

• Evaluation by an experienced psychiatrist or anesthesiologist before ketamine
• Close monitoring of blood pressure, heart rhythm, and symptoms during and after each session
• Potentially longer in-clinic observation times

Some clinics may choose not to provide ketamine to patients on MAOIs, while others will proceed with dose adjustment, slower titration, and extended monitoring.

Clear warning: Patients on MAOIs should never start, stop, or change their antidepressant or ketamine dosing without explicit medical guidance. The potential for serious cardiovascular reactions, including hypertensive crisis, is real.

Ketamine With Mood Stabilizers and Antipsychotics

Many people with bipolar disorder, schizoaffective disorder, or severe major depressive disorder receive mood stabilizers (like lithium, valproate, or lamotrigine) or antipsychotics (like quetiapine, risperidone, or olanzapine). The good news: many of these patients can still be candidates for ketamine.

For bipolar depression, clinical practice often involves keeping a mood stabilizer on board while adding ketamine. This approach helps reduce the risk of mood switching into mania or hypomania.

Research suggests some mood stabilizers and antipsychotics may blunt certain ketamine effects, while others seem largely neutral. However, limited data, small sample sizes, and differing doses mean results must be applied cautiously.

Because psychosis risk and mood instability are serious concerns, decisions about these combinations must be made by a psychiatrist familiar with both ketamine and the underlying diagnosis.

Ketamine and Lithium or Valproate

Several randomized controlled trials and open-label studies up to 2024 have not shown a meaningful safety problem when lithium or valproate is combined with ketamine at standard antidepressant doses.

Research to date has not demonstrated that lithium meaningfully enhances ketamine’s antidepressant effect, but it also doesn’t appear to significantly interfere with ketamine’s benefit in most patients.

Monitoring considerations:

• Lithium levels and kidney/thyroid function should continue as usual
• Watch for overlapping side effects like tremor, nausea, or sedation
• These are generally manageable with good communication

For bipolar disorder, many clinicians prefer to maintain a therapeutic lithium or valproate level when initiating ketamine to reduce the risk of mood elevation or mixed states.

Patient note: Don’t adjust your lithium or valproate dose on your own before ketamine. Any changes should be discussed with your prescribing psychiatrist.

Ketamine and Lamotrigine

Lamotrigine is a mood stabilizer frequently used for bipolar depression and sometimes as an adjunct in unipolar depression.

Several small human studies suggest lamotrigine may dampen some of ketamine’s acute effects, including dissociation and certain brain activity changes. It may also reduce the intensity or duration of ketamine’s antidepressant benefit in some individuals, though findings are mixed. This reinforces why understanding how ketamine works in the brain matters when evaluating medication interactions.

Think of lamotrigine as a “possible attenuator” rather than a proven contraindication. Some clinics consider dose adjustments or careful outcome tracking if a patient on lamotrigine has a weaker-than-expected response to ketamine.

Practical clinical approach:

1. Maintain lamotrigine early on
2. Evaluate the first several ketamine sessions
3. Only consider medication changes if the response is poor and other causes (dose, frequency, psychosocial stressors) have been addressed

Caution: Never stop lamotrigine prior to treatment abruptly. This carries the risk of seizure and mood destabilization. Always consult with your prescribing physician if questions about ketamine interactions arise.

Ketamine and Antipsychotic Medications

Antipsychotics, such as quetiapine, risperidone, olanzapine, aripiprazole, clozapine, and haloperidol, are used not only for schizophrenia and schizoaffective disorder but also as adjunctive treatments in major depressive disorder and bipolar disorder.

Here’s the key theme from human studies: some antipsychotics can reduce ketamine’s psychotomimetic and dissociative symptoms and may blunt certain brain changes. For a few agents (like risperidone or clozapine), this may also dampen aspects of ketamine’s antidepressant effect, but evidence is inconsistent and mostly based on small samples.

Short-term ketamine treatment, when closely monitored, has not been shown to reliably worsen psychosis. However, people with a history of schizophrenia-spectrum disorders require especially careful screening and follow-up.

Continuation of necessary antipsychotics is usually preferred for safety. Clinicians adjust doses only if side effects, excessive sedation, blood pressure changes, or poor ketamine response become problematic.

Advice for patients:

• Disclose any history of psychosis, mania, or hospitalization
• Never stop an antipsychotic for ketamine without psychiatric supervision
• Expect your team to monitor closely for changes in thought content or behavior after sessions

Ketamine and Other Common Medications

Many patients undergoing ketamine therapy also take medications for various mental health conditions beyond depression, including anxiety disorders, ADHD, chronic pain, sleep problems, or high blood pressure. These combinations can influence both safety and effectiveness.

Potential interactions typically involve three main issues:

1. Impact on ketamine’s antidepressant effects
2. Additive side effects (like sedation or blood pressure spikes)
3. Underlying conditions (such as heart disease) that require extra caution

Always bring a full list of prescription medications, over-the-counter drugs, and supplements to your ketamine provider, especially when reviewing what disqualifies you from ketamine therapy.

Benzodiazepines and Other GABAergic Medications

Benzodiazepines, like alprazolam (Xanax), clonazepam (Klonopin), lorazepam (Ativan), and diazepam (Valium), are among the most important medications to review before ketamine. A 2021 systematic review and multiple human studies show benzodiazepine use can shorten or weaken ketamine’s antidepressant response.

Here’s why: benzodiazepines enhance GABA activity, which can counterbalance the glutamate-driven plasticity that ketamine relies on. Higher benzo doses have been linked to poorer ketamine outcomes in pharmacodynamic interactions.

What many clinics do:

• Attempt to reduce benzodiazepine doses when clinically safe
• Adjust timing so doses aren’t taken right before sessions
• Use small rescue doses if severe anxiety emerges during infusions

Other GABA-acting agents also matter:

Medication Type	Examples	Concern Level
Z-drugs	Zolpidem, eszopiclone	May modify effects; less evidence
Gabapentinoids	Gabapentin, pregabalin	May add sedation; individualized
Other	Topiramate	Limited data; case-by-case decisions

Critical guidance: Never abruptly stop a long-term benzodiazepine on your own. Withdrawal and seizure risks are real. Discuss a gradual taper or timing changes with your prescriber if you’re planning ketamine therapy.

Stimulants and ADHD Medications

Many adults evaluated for ketamine have ADHD and are taking stimulants such as Adderall (mixed amphetamine salts), Vyvanse (lisdexamfetamine), Ritalin or Concerta (methylphenidate), or non-stimulant options like atomoxetine.

Both stimulants and ketamine can increase blood pressure and heart rate. In some individuals, they can raise anxiety or restlessness. The key concern is additive cardiovascular and anxiety effects rather than direct toxicity. This is why clinics closely monitor vitals and follow protocols that support how safe ketamine is when used under medical supervision.

Many patients tolerate this combination well when blood pressure is monitored, and doses are adjusted. Some clinics recommend skipping or reducing the morning stimulant dose on ketamine days, especially early in treatment, to avoid overstimulation.

Decisions differ by person:

• For some, keeping the usual stimulant dose improves focus and integration after sessions
• For others, a lower dose or non-stimulant strategy may be safer

Patient tip: Inform your ketamine provider about all ADHD medications. Don’t alter dosing without input from both your ketamine clinician and the prescriber managing your ADHD.

Pain Medications, Opioids, and Over-the-Counter Drugs

Ketamine is sometimes used for chronic pain (neuropathic pain, CRPS, fibromyalgia), and many such patients take opioids (oxycodone, hydrocodone, morphine), NSAIDs (ibuprofen, naproxen), or other analgesics.

The concurrent use of opioids and ketamine can cause sedation and, at high doses, slowed breathing. In controlled, low-dose ketamine protocols, risk is generally low but requires careful monitoring, especially in people with lung disease, sleep apnea, or heavy sedative use.

Potential benefit: Ketamine may allow gradual opioid dose reduction over time for some chronic pain patients. However, opioid tapers must be planned and supervised to avoid withdrawal and pain flares.

Common over-the-counter pain relievers (acetaminophen, ibuprofen, naproxen) usually don’t have clinically significant interactions with ketamine at standard doses. Overall, liver and kidney function should be considered in long-term users.

Reminder: Report use of other substances that affect the cardiovascular system, like decongestants containing pseudoephedrine or phenylephrine, because these can add to ketamine-induced blood pressure spikes.

Blood Pressure and Heart Medications

Ketamine typically raises blood pressure and heart rate briefly during and after ketamine administration. People on antihypertensive medications or with heart conditions need individualized planning.

Medication Class	Typical Approach
Beta-blockers	Usually continued; timing may be adjusted.
ACE inhibitors	Usually continued
ARBs	Usually continued
Calcium channel blockers	Usually continued

Patients with poorly controlled hypertension, arrhythmias, a recent heart attack, or severe valvular disease may need:

• Cardiology clearance
• More intensive monitoring
• Consideration of alternative therapy

Ketamine use is generally avoided or used extremely cautiously in individuals with certain unstable cardiac conditions. Pre-treatment EKGs and labs may be requested in higher-risk patients.

Patient guidance: Don’t skip your blood pressure medication before ketamine unless your cardiologist or ketamine physician specifically instructs you to. Bring home blood pressure logs if available.

A Safe Path to More Effective Healing

Ketamine therapy can often be safely combined with other medications and supportive treatments, especially when coordinated by a qualified clinical team. For most patients, the best outcomes come from an individualized plan that considers current prescriptions, mental health history, and treatment goals. With proper monitoring, combination care can improve results and support long-term progress.

At New Life Ketamine Clinic, we provide ketamine therapy in Dayton through a safe, personalized care approach. We also support addiction treatment, anxiety treatment, bipolar disorder treatment, and chronic pain management treatment as part of an individualized plan. Schedule a consultation today to learn how our team can help you move forward with confidence, clarity, and support.

Frequently Asked Questions

Do I need to stop my current antidepressant before starting ketamine therapy?

Most patients do not need to stop SSRIs or SNRIs before starting ketamine therapy. Esketamine (Spravato) is FDA-approved specifically for use alongside an oral antidepressant. Since ketamine works differently, combining treatments is usually safe. Only change medications under a clinician’s guidance.

Can ketamine replace all of my other medications if it works for me?

Ketamine is typically an add-on treatment rather than a full replacement for existing medications. If symptoms improve and remain stable over time, your clinician may gradually reduce certain medications. Changes must be done slowly and carefully. Stopping psychiatric medications abruptly can trigger relapse or withdrawal.

Is it safe to drink alcohol or use cannabis while I’m receiving ketamine treatments?

Alcohol is strongly discouraged during ketamine treatment because it can increase sedation, impair recovery, and reduce treatment benefits. Combining alcohol and ketamine may also raise risks like slowed breathing and poor judgment. Cannabis may affect mood and perception, so clinics often recommend avoiding it near sessions.

What if I’m on multiple psychiatric medications? Am I still a candidate for ketamine?

Many ketamine patients take multiple psychiatric medications. Eligibility depends on your diagnosis, medical history, and how those medications interact with ketamine. A full pre-treatment review helps determine safety and whether adjustments are needed. Multiple medications don’t automatically disqualify you, but transparency is essential.

How quickly will my clinicians know if my other medications are interfering with ketamine’s effects?

Clinicians often identify patterns within the first 2–4 ketamine sessions. If improvement is limited and interacting medications (like high-dose benzodiazepines or lamotrigine) are involved, your team may consider careful adjustments. Decisions must balance a stronger ketamine response with risks like anxiety or destabilization.